Chester County News and Community Website
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced its financial results for the third quarter ending September 30, 2024, alongside significant progress in its Alzheimer’s treatment pipeline.
Annovis Bio Advances Alzheimer’s Treatment with Phase 3 Trials and Financial Updates Read More
AUSTIN, TX, and MALVERN, PA — In a promising development for Alzheimer’s disease diagnostics, Veravas, Inc. and Phanes Biotech have announced their collaboration to create a blood-based test for detecting …
Veravas and Phanes Biotech Collaborate to Innovate Alzheimer’s Disease Testing Read More
HARRISBURG, PA — The Pennsylvania Department of Aging (PDA) held its annual virtual forum on Thursday, drawing 488 attendees to a comprehensive discussion on brain health and community support. This …
Pennsylvania Department of Aging Hosts Virtual Forum to Tackle Alzheimer’s and Related Disorders Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is gearing up to showcase critical research at the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference, scheduled from October 29 to …
Annovis Bio to Present Key Alzheimer’s Research at CTAD Conference Read More
HARRISBURG, PA — In a significant move to address the growing needs of older adults affected by Alzheimer’s and dementia, Governor Josh Shapiro has signed legislation establishing Pennsylvania’s first-ever Alzheimer’s, …
Pennsylvania Establishes First Alzheimer’s and Dementia Division with Bipartisan Backing Read More
WEST BRANDYWINE, PA — Freedom Village at Brandywine recently marked a milestone with its third annual Walk to End Alzheimer’s, a pivotal event that underscores the community’s commitment to fighting a …
Freedom Village Hosts Successful Third Annual Walk to End Alzheimer’s Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has made strides in the fight against neurodegenerative diseases with the filing of three new patents. These cover novel combination therapies involving their …
Annovis Bio Files Patents for Innovative Therapies in Neurodegenerative Disease Treatment Read More
Every September — World Alzheimer’s Month — the public is reminded of startling statistics about this devastating form of dementia that affects memory, thinking, and behavior. The lifetime risk for …
Understanding Alzheimer’s: Key Signs and Proactive Steps for Caregivers Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) announced new preclinical data showing the positive combined effects of its lead compound, buntanetap, with the GLP-1 agonist dulaglutide (Trulicity®) in an …
Annovis Bio Shows Synergistic Effect of Buntanetap and Dulaglutide in Alzheimer’s Treatment Read More MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has received approval from the U.S. Food and Drug Administration (FDA) to transition to a new solid form of buntanetap in future …
Annovis Bio Gains FDA Approval for New Form of Neurodegenerative Drug Read More